Alysicarpus vaginalis Bio-Actives as ESR Signaling Pathway Inhibitor for Breast Cancer Treatment: A Network Pharmacology Approach
- 6 October 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Nutrition and Cancer
- Vol. 74 (6), 2222-2234
- https://doi.org/10.1080/01635581.2021.1986080
Abstract
In our previous study Alysicarpus vaginalis (AV) has appeared as a promising target for breast cancer hence we have screened potential targets by in silico, In Vitro and In Vivo methods. A network pharmacology (NP) approach involves prediction and validating of targets via molecular modeling, western blotting and In Vivo MNU-induced mammary cancer. The PPI network showed the 573 edges between 214 nodes (targets) that are involved in breast cancer and important one are ESR-1, ESR-2, AR, EGFR, NOS3, MAPK, KDR, SRC and MET. Compound-target-pathway network involves 04 compounds and 221 interactive protein targets associated with breast cancer. GO and KEGG enrichment analysis predicted the ERR, c-MET, PDGFR-α/β, EGFR, and VEGF as a key targets in the breast cancer treatment which are validated via molecular modeling. Expression of ER-α, AR and EGFR were significantly down regulated by AV in MCF-7 cell line. In addition, the immunoreactivity of ER-α was reduced significantly in MNU-induced mammary carcinoma, which is a key target in ER + breast cancer. Overall, this study scientifically light ups the pharmacological mechanism of AV in the treatment of breast cancer, strongly associated with the regulation of ESR signaling pathway.This publication has 29 references indexed in Scilit:
- Interpretation of ER and Her2neu hormonal receptor in breast cancerMedical Journal Armed Forces India, 2015
- Hepatoprotective Activity of Ethanolic Extract of Alysicarpus vaginalis against Nitrobenzene-Induced Hepatic Damage in RatsSouth Indian Journal of Biological Sciences, 2015
- Hypoxia-inducible factor 1 and breast cancer metastasisJournal of Zhejiang University-SCIENCE B, 2015
- Estrogen and progesterone receptors in breast cancerFuture Oncology, 2014
- A Network Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Ge-Gen-Qin-Lian Decoction for Treatment of Type 2 DiabetesEvidence-Based Complementary and Alternative Medicine, 2014
- Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesisSteroids, 2013
- Benjamini–Hochberg MethodPublished by Springer Science and Business Media LLC ,2013
- Botanical Drugs, Synergy, and Network Pharmacology: Forth and Back to Intelligent MixturesPlanta Medica, 2011
- Discovery of NM23-H2 as an estrogen receptor β-associated protein: Role in estrogen-induced gene transcription and cell migrationThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune networkIET Systems Biology, 2007